Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ

$96.71

$+0.83

(+0.87%)

Pre-Market

Rhythm Pharmaceuticals, Inc. (RYTM) Live Price Chart

Last updated: ⁦2026-09-16 13:20:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Rhythm Pharmaceuticals, Inc. (RYTM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $96.71, with a market capitalisation of $7.05B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $74.50 to $122.20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$7.05B
Open	$95.88
Day's High	$122.20
Day's Low	$3.04
Previous Close	$96.77
Volume	4.28K
Average Volume	731.11K
P/E Ratio	--
52-Week High	$122.20
52-Week Low	$74.50
Dividend Yield	--
Earnings Date	--

Rhythm Pharmaceuticals, Inc. (RYTM) Pre-Market Stock Price

Rhythm Pharmaceuticals, Inc. (RYTM) is trading at $96.71 in pre-market trading as of 2026-09-16 13:15:00, down 0.06% ($0.06) from the previous close of $96.77

Pre-market trading shows how investors are pricing RYTM before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Rhythm Pharmaceuticals, Inc. (RYTM) 7-Day Stock Price Change

Over the past seven days, Rhythm Pharmaceuticals, Inc. (RYTM) moved from $102.74 to $96.71, representing a decline of 5.87% ($6.03).

The stock traded between $95.88 and $106.57 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 594.69 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

RYTM 52-Week Price Position

Position in Range: 46.6%

52W Low$74.50

52W High$122.20

RYTM is currently trading at $96.71, placing it 46.6% of the way from its 52-week low of $74.50 to its 52-week high of $122.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Rhythm Pharmaceuticals, Inc. (RYTM)?

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Rhythm Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	414
Exchange	NASDAQ
Company Website	https://www.rhythmtx.com

How to Buy Rhythm Pharmaceuticals, Inc. (RYTM) Stock on MEXC

Eligible investors can buy real shares of Rhythm Pharmaceuticals, Inc. (RYTM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RYTM and Place Your Order

Open the RealStocks trading page and search for RYTM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Rhythm Pharmaceuticals, Inc. (RYTM) stock price today?

Rhythm Pharmaceuticals, Inc. (RYTM) is currently trading at $ 96.71, down 0.06% ($0.06) from the previous close of $ 96.77. Intraday prices update in real time during regular trading hours.

2.Is RYTM stock going up or down today?

As of 2026-09-16 13:15:00, RYTM is trading at $ 96.71, down 0.06% ($0.06) from its previous close of $ 96.77. The stock has traded between $ 3.04 and $ 122.20 during today’s regular session. Past price movements do not guarantee future results.

3.What is RYTM pre-market price?

As of 2026-09-16 13:15:00, RYTM is trading at $ 96.71 in pre-market trading, down 0.06% ($0.06) from the previous close of $ 96.77. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RYTM after-hours price?

As of 2026-09-16 13:15:00, RYTM is trading at $ 94.06 in after-hours trading, down 2.80% ($2.71) from the regular-session close of $ 96.77. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RYTM stock trading now?

RYTM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RYTM sit relative to its 52-week high and low?

Over the past 52 weeks, RYTM has traded between a low of $ 74.50 and a high of $ 122.20. At $ 96.71, the stock is positioned 46.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Rhythm Pharmaceuticals, Inc. in?

Rhythm Pharmaceuticals, Inc. (RYTM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Rhythm Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Rhythm Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 7.05B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RYTM valued in terms of P/E ratio and EPS?

RYTM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.05. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Rhythm Pharmaceuticals, Inc. pay a dividend?

Rhythm Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.